CARDIOPULMONARY BYPASS
Clinical trials for CARDIOPULMONARY BYPASS explained in plain language.
Never miss a new study
Get alerted when new CARDIOPULMONARY BYPASS trials appear
Sign up with your email to follow new studies for CARDIOPULMONARY BYPASS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to shield kidneys during heart surgery
Disease control TerminatedThis study tests a single dose of ravulizumab given before heart surgery to see if it can prevent kidney damage and serious kidney problems in people with chronic kidney disease. About 736 adults will take part. The goal is to reduce the risk of major kidney events within 90 days…
Matched conditions: CARDIOPULMONARY BYPASS
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Heart-Lung machine registry ends early – no major findings
Knowledge-focused TerminatedThis registry studied the safety and performance of the HL 40 heart-lung machine and its temperature probes in 184 patients having heart, chest, or blood vessel surgery. The goal was to see how often the devices worked without failure or caused related side effects. The study was…
Matched conditions: CARDIOPULMONARY BYPASS
Sponsor: Maquet Cardiopulmonary GmbH • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC